Tier 2 — strong

Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans

V V Ranade, J C Somberg
American journal of therapeutics 2001 8(5):345-57

Bibliography

PubMed
PMID 11550076
DOI
10.1097/00045391-200109000-00008
Funding
Funding is not specified in the indexed abstract or accessible funding metadata. Consult the original publication for the declaration.
Competing interests
A competing-interest declaration is not available in the indexed abstract or accessible disclosure metadata.

Study snapshot

DesignNarrative pharmacokinetic review
ModelHuman evidence synthesis
SampleReview of multiple pharmacokinetic studies; no new cohort
InterventionMultiple oral magnesium salts and medicinal preparations
DurationVaried across reviewed studies
EndpointsBioavailability; Pharmacokinetics; Formulation-dependent effects

What the study showed, in plain terms

This publication examines bioavailability, pharmacokinetics, formulation-dependent effects. Study population or evidence base: Review of multiple pharmacokinetic studies; no new cohort. Intervention or exposure: Multiple oral magnesium salts and medicinal preparations.

Key findings

The review describes how magnesium salts and their associated anions influence elemental-magnesium delivery and pharmacological effects.

What this study can and cannot tell us

An older narrative review with heterogeneous source studies. It does not provide direct modern head-to-head evidence for L-threonate versus bisglycinate.

Related papers in the corpus

Tier 2
Magnesium bioavailability from magnesium citrate and magnesium oxide
J S Lindberg et al. · Journal of the American College of Nutrition · 1990
Tier 2
Bioavailability of US commercial magnesium preparations
M Firoz et al. · Magnesium research · 2001
Tier 2
Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects
Tanja Werner et al. · Magnesium research · 2019
Tier 1
Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium (MAGSHAPETM Microcapsules) Versus Other Magnesium Sources
David Pajuelo et al. · Nutrients · 2024
Tier 2
Magnesium bioavailability after administration of sucrosomial® magnesium: results of an ex-vivo study and a comparative, double-blinded, cross-over study in healthy subjects
E Brilli et al. · European review for medical and pharmacological sciences · 2018
Tier 2
Comparing the Bioavailability of Two Seawater-Derived Magnesium Preparations
Brian K McFarlin et al. · Journal of medicinal food · 2025

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Biohack Blueprint Research